Blueprint Medicines Corp (BPMC)
90.46
+0.13
(+0.14%)
USD |
NASDAQ |
Dec 24, 16:00
Blueprint Medicines Shareholders Equity (Quarterly): 313.15M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 15.63B |
| PTC Therapeutics Inc | -1.054B |
| Biomarin Pharmaceutical Inc | 5.413B |
| Regeneron Pharmaceuticals Inc | 29.33B |
| SpringWorks Therapeutics Inc | 532.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.200B |
| Total Liabilities (Quarterly) | 886.50M |
| Debt to Equity Ratio | 1.234 |
| Current Ratio | 3.318 |
| Net Debt Paydown Yield | -0.84% |